Peace Corps official reflects on Global Health Service Partnership

In this post in the AIDS.gov blog, Buck Buckingham, director of the Peace Corps Office of Global Health and HIV, reflects on the Global Health Service Partnership (GHSP), launched by Peace Corps Director Aaron Williams in March, writing, "Although this partnership is an exciting innovation for the Peace Corps, the commitment to health which it reflects finds deep roots in our history, as Director Williams described at the launch on March 13." He adds, "The partnership will take on fuller definition this summer, when invited physicians and nurses from academic health centers and other centers of expertise in the United States and the three initial countries in the pilot program will gather in Washington, D.C. on July 21 to further plan the contours of its work" (6/7).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients